Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Colorectal Cancer Clinical Trials in Portland | 178 Studies

Clinical Trials Colorectal CancerPortland

Colorectal Cancer Clinical Trials in Portland

Find 178 clinical trials for colorectal cancer near Portland, Oregon. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 178 trials

CompletedPhase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesThe purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or…NCT03126110·Los Angeles, California and 37 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingBasket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 AlterationsThis trial studies how well tucatinib works for solid tumors that make either more HER2 or a different type of HER2 than usual (HER2 alterations) The solid tumors studied in this…NCT04579380·Phoenix, Arizona and 107 others

CompletedMaximizing Yield of the Fecal Immunochemical Test for Colorectal Cancer ScreeningColorectal cancer (CRC) is a leading cause of cancer death in the United States. Screening for CRC reduces CRC mortality, yet rates of screening in the United States remain low.NCT01634126·Portland, Oregon

CompletedS0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00049335·Mobile, Alabama and 89 others

RecruitingcfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseThis is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer…NCT05366881·Duarte, California and 16 others

Active not recruitingA Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsThe main purpose of this study is to establish the safety and the recommended dose of TRK-950 in combination with FOLFIRI, Gemcitabine / Cisplatin, Gemcitabine / Carboplatin…NCT03872947·Scottsdale, Arizona and 13 others

UnknownCAR-macrophages for the Treatment of HER2 Overexpressing Solid TumorsPhase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.NCT04660929·Duarte, California and 6 others

TerminatedA Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid TumorsA multicenter trial to investigate TBio-4101, an autologous, neoantigen-selected, tumor-reactive TIL product, in patients with advanced solid malignancies.NCT05576077·Irvine, California and 12 others

TerminatedEfficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal AdenocarcinomaThe primary objective of this study is to compare the additive efficacy of SIM versus placebo in combination with leucovorin (folinic acid), irinotecan, and fluorouracil (FOLFIRI)…NCT01479465·Huntsville, Alabama and 108 others

CompletedAn Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has SpreadThis purpose of this study is to evaluate nivolumab (BMS-936558) in combination with standard of care (SOC) chemotherapy with bevacizumab for the treatment of first-line…NCT03414983·Birmingham, Alabama and 48 others

CompletedCombination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00056030·Mobile, Alabama and 161 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

CompletedCalcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving IrinotecanRATIONALE: Calcium aluminosilicate anti-diarrheal (CASAD) may help treat and prevent diarrhea caused by irinotecan.NCT00748215·Portland, Oregon and 1 other

RecruitingTesting the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur TrialThis phase III trial compares the addition of total ablative therapy to the usual systemic therapy versus the usual systemic therapy alone in treating patients with advanced…NCT05673148·Kingman, Arizona and 186 others

TerminatedOxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal CancerRATIONALE: Drugs used in chemotherapy, such as oxaliplatin, capecitabine, and floxuridine, work in different ways to stop the growth of tumor cells, either by killing the cells or…NCT00268463·Concord, California and 30 others

TerminatedStudy of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal CancerStudy BT-CL-PGG-CRC1031 is a Phase 3, open-label, randomized, multi-center study.NCT01309126·Florence, Alabama and 52 others

RecruitingStudy of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid TumorsThis Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx)…NCT06974110·Phoenix, Arizona and 14 others

CompletedVaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal CancerRATIONALE: Vaccines made from a gene-modified virus and a person's white blood cells may make the body build an effective immune response to kill tumor cells.NCT00103142·Washington D.C., District of Columbia and 5 others

CompletedStudy of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal CancerThis is a multicenter, randomized, open-label, 3-arm Phase 3 study to evaluate encorafenib + cetuximab plus or minus binimetinib versus Investigator's choice of either…NCT02928224·Phoenix, Arizona and 417 others

Active not recruitingA Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsTo evaluate the efficacy of naporafenib administered with trametinib in patients with rat sarcoma viral oncogene (RAS) Q61X solid tumors * To evaluate the safety and tolerability…NCT05907304·San Francisco, California and 28 others

PreviousPage 5 of 9Next

Other Conditions in Portland

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma